OPKO Health, Inc.

OPKO Health, Inc. is a healthcare company that focuses on the development and commercialization of innovative medical products and services. The company is involved in various therapeutic areas, including endocrinology and diagnostics. OPKO offers a range of therapies, notably Ngenla and Rayaldee, which are designed to address specific health conditions. The organization is also engaged in extensive research activities, with a dedicated pipeline for new product development and a commitment to scientific publications and presentations. OPKO maintains partnerships with several prominent institutions and organizations, enhancing its research and development capabilities. The company is headquartered in Miami, Florida, and provides information regarding its leadership, locations, and investor relations on its website. OPKO Health is publicly traded under the ticker symbol OPK.

Driving directions from: